"MBX is entering 2025 with strong momentum following significant and transformational progress in 2024,” said Kent Hawryluk, President and Chief Executive Officer of MBX Biosciences. "We are poised to ...
Maximize efficiency and cut costs with smart AI, automation, and cloud strategies. Discover how FIS achieved sustainable growth with these solutions!